Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Proof That Chronic Lyme Disease Exists

View through CrossRef
The evidence continues to mount that Chronic Lyme Disease (CLD) exists and must be addressed by the medical community if solutions are to be found. Four National Institutes of Health (NIH) trials validated the existence and severity of CLD. Despite the evidence, there are physicians who continue to deny the existence and severity of CLD, which can hinder efforts to find a solution. Recognizing CLD could facilitate efforts to avoid diagnostic delays of two years and durations of illness of 4.7 to 9 years described in the NIH trials. The risk to society of emerging antibiotic-resistant organisms should be weighed against the societal risks associated with failing to treat an emerging population saddled with CLD. The mixed long-term outcome in children could also be examined. Once we accept the evidence that CLD exists, the medical community should be able to find solutions. Medical professionals should be encouraged to examine whether: (1) innovative treatments for early LD might prevent CLD, (2) early diagnosis of CLD might result in better treatment outcomes, and (3) more effective treatment regimens can be developed for CLD patients who have had prolonged illness and an associated poor quality of life.
Title: Proof That Chronic Lyme Disease Exists
Description:
The evidence continues to mount that Chronic Lyme Disease (CLD) exists and must be addressed by the medical community if solutions are to be found.
Four National Institutes of Health (NIH) trials validated the existence and severity of CLD.
Despite the evidence, there are physicians who continue to deny the existence and severity of CLD, which can hinder efforts to find a solution.
Recognizing CLD could facilitate efforts to avoid diagnostic delays of two years and durations of illness of 4.
7 to 9 years described in the NIH trials.
The risk to society of emerging antibiotic-resistant organisms should be weighed against the societal risks associated with failing to treat an emerging population saddled with CLD.
The mixed long-term outcome in children could also be examined.
Once we accept the evidence that CLD exists, the medical community should be able to find solutions.
Medical professionals should be encouraged to examine whether: (1) innovative treatments for early LD might prevent CLD, (2) early diagnosis of CLD might result in better treatment outcomes, and (3) more effective treatment regimens can be developed for CLD patients who have had prolonged illness and an associated poor quality of life.

Related Results

APPLICATION OF INTELLIGENT MULTIAGENT APPROACH TO LYME DISEASE SIMULATION
APPLICATION OF INTELLIGENT MULTIAGENT APPROACH TO LYME DISEASE SIMULATION
ObjectiveThe objective of this research is to develop the model for calculating the forecast of the Lyme disease dynamics what will help to take effective preventive and control me...
Lyme Arthritis of the Pediatric Ankle
Lyme Arthritis of the Pediatric Ankle
Lyme arthritis results from acute inflammation caused by the spirochete Borrelia burgdorferi. The number of cases per year has been rising since 2006, with ...
Predictive Model of Lyme Disease Epidemic Process Using Machine Learning Approach
Predictive Model of Lyme Disease Epidemic Process Using Machine Learning Approach
Lyme disease is the most prevalent tick-borne disease in Eastern Europe. This study focuses on the development of a machine learning model based on a neural network for predicting ...
Autoimmune Arthritides, Rheumatoid Arthritis, Psoriatic Arthritis, or Peripheral Spondyloarthritis Following Lyme Disease
Autoimmune Arthritides, Rheumatoid Arthritis, Psoriatic Arthritis, or Peripheral Spondyloarthritis Following Lyme Disease
ObjectiveTo describe systemic autoimmune joint diseases that develop following Lyme disease, and to compare their clinical features with those of Lyme arthritis (LA).MethodsWe revi...
A-267 Evaluation of the Quidel Sofia 2 Rapid Lyme Test in a Modified Two-tier Testing Protocol
A-267 Evaluation of the Quidel Sofia 2 Rapid Lyme Test in a Modified Two-tier Testing Protocol
Abstract Background Several Modified two-tier testing algorithms (MTTT) for Lyme disease involving sequential enzyme immunoassay...
Immunopathogenetic features of lyme disease
Immunopathogenetic features of lyme disease
The aim: to study the immunological features of Lyme disease and the pathophysiological mechanisms that lead to multiple organ damage. Materials and methods: articles and studies p...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
The Lyme Disease Controversy: An AI-Driven Discourse Analysis of a Quarter Century of Academic Debate and Divides
The Lyme Disease Controversy: An AI-Driven Discourse Analysis of a Quarter Century of Academic Debate and Divides
ABSTRACTThe scientific discourse surrounding Chronic Lyme Disease (CLD) and Post-Treatment Lyme Disease Syndrome (PTLDS) has evolved over the past twenty-five years into a complex ...

Back to Top